In this study, we have shown the production and initial characterization toward a new mouse model of CMT2P, where a knock-in of the C698R Lrsam1 mutation was introduced into the mouse genome. This evidence concerns the gene LRSAM1 and Charcot-Marie-Tooth disease axonal type 2P.